Eosinophilic pneumonia epidemiology and demographics

Pneumonia Main Page
Eosinophilic pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Eosinophilic pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Eosinophilic pneumonia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Eosinophilic pneumonia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Eosinophilic pneumonia epidemiology and demographics
CDC onEosinophilic pneumonia epidemiology and demographics
Eosinophilic pneumonia epidemiology and demographics in the news
Blogs on Eosinophilic pneumonia epidemiology and demographics
Directions to Hospitals Treating Eosinophilic pneumonia
Risk calculators and risk factors for Eosinophilic pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

• The incidence of CEP in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004 [3].
• In registries of interstitial lung disease (ILD) in Europe, CEP accounted for 0 to 2.5 percent of cases of ILD [4].
• Women develop CEP about twice as often as men.
• A majority of patients are nonsmokers.